Ranbaxy Laboratories, a subsidiary of Daiichi Sankyo of Japan, has reported a consolidated
net profit of Rs 754 crore in the third quarter of current calendar year as
against loss of Rs 464 crore in the corresponding quarter of last fiscal due to
forex gain.
Consolidated net sales rose by 31 percent year-on-year to Rs
2,651 crore during the same quarter.
Other income increased significantly to Rs 66 crore in the
quarter ended September 2012 from Rs 28.5 crore in a year ago period.
Ranbaxy Labs has reported total foreign exchange gain of Rs
461.7 crore during July-September period.
Source: www.moneycontrol.com
Thanks,
Gaurav Agarwal
Head Dealer
DENIP Consultants Pvt Ltd
No comments:
Post a Comment